Sign In
Buy KRYS
$301.82
+8.61 (+2.94%)
At Close: Jun 03, 2026
Krystal Biotech Announces Pricing of Upsized $125 Million Public Offering of Common Stock
08:51pm, Tuesday, 02'nd Feb 2021
PITTSBURGH, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. (NASDAQ: KRYS) (the “Company), the leader in redosable gene therapies for rare diseases, today announced that it has priced the pre
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) * Catalent Inc (NYSE: CTLT) * CureVac N.V. (NASDAQ: CVAC) (follow-on buying after a 250% advance on its debut Friday) * Fortress Bi
Krystal Biotech’s ‘Promising’ Cystic Fibrosis Drug Scores Orphan Designation
08:05am, Tuesday, 18'th Aug 2020
Gene therapy company Krystal Biotech (KRYS) has announced that the U.S. Food & Drug Administration (FDA) has granted Orphan Drug Designation to KB407, currently in pre-clinical development for the tre
Krystal Biotech’s KB407 Granted Orphan Drug Designation by the FDA to Treat Patients With Cystic Fibrosis
08:01pm, Monday, 17'th Aug 2020
The company is on track to file an IND for KB407 in 2021PITTSBURGH, Aug. 17, 2020 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (Nasdaq:KRYS), a fully integrated gene therapy company driven by its proprie
What Type Of Shareholders Own The Most Number of Krystal Biotech, Inc. (NASDAQ:KRYS) Shares?
12:54pm, Tuesday, 11'th Aug 2020
If you want to know who really controls Krystal Biotech, Inc. (NASDAQ:KRYS), then you'll have to look at the makeup of...
What Kind Of Investors Own Most Of Krystal Biotech, Inc. (NASDAQ:KRYS)?
12:48pm, Tuesday, 11'th Aug 2020
A look at the shareholders of Krystal Biotech, Inc. (NASDAQ:KRYS) can tell us which group is most powerful...
Krystal Biotech Reports Second Quarter 2020 Financial Results and Provides Update on Operational Progress
12:00pm, Monday, 10'th Aug 2020
Initiated the pivotal GEM-3 clinical study evaluating B-VEC in DEB patients Today announced enrollment of 1st patient in Phase 2 clinical study evaluating KB105 in ARCI patientsOn track t
The
SG Americas Securities LLC Makes New $856,000 Investment in Krystal Biotech Inc (NASDAQ:KRYS)
06:00am, Sunday, 02'nd Aug 2020
SG Americas Securities LLC bought a new position in Krystal Biotech Inc (NASDAQ:KRYS) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fu
Krystal Biotech to Present at the William Blair BioTech Conference
12:00pm, Thursday, 30'th Jul 2020
PITTSBURGH, July 30, 2020 (GLOBE NEWSWIRE) -- Krystal Biotech Inc., (“Krystal”) (NASDAQ: KRYS), a fully integrated gene therapy company driven by its proprietary, engineered herpes simplex virus t
* The randomized, double-blind GEM-3 trial will compare repeat dosing of either B-VEC or placebo in approximately 30 dystrophic epidermolysis bullosa (DEB) patients * Top line data and BLA fili
Krystal Biotech Appoints Whitney Ijem as Senior Vice President, Strategy and Business Development
12:00pm, Monday, 20'th Jul 2020
PITTSBURGH, July 20, 2020 -- Krystal Biotech, Inc. (Nasdaq:KRYS), a fully integrated gene therapy company driven by its proprietary, engineered herpes simplex virus type 1.
Invesco Ltd. Decreases Stake in Krystal Biotech Inc (NASDAQ:KRYS)
04:44pm, Thursday, 16'th Jul 2020
Invesco Ltd. reduced its stake in shares of Krystal Biotech Inc (NASDAQ:KRYS) by 57.9% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 34
With Its Film Fest Postponed by the Pandemic, Rare-Disease Group Starts Its Own Streaming Channel
12:00am, Wednesday, 08'th Jul 2020
Rare Outreach Coalition has launched The Disorder Channel to showcase rare disease films and videos for free on Roku® and Amazon Fire TV.
Victory Capital Management Inc. Sells 515 Shares of Krystal Biotech Inc (NASDAQ:KRYS)
04:20am, Sunday, 05'th Jul 2020
Victory Capital Management Inc. lowered its position in Krystal Biotech Inc (NASDAQ:KRYS) by 24.5% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commissi
